Atezolizumab: A New Treatment for Breast Cancer
What is Atezolizumab?
Atezolizumab is a type of immunotherapy drug that works by blocking the PD-L1 protein on cancer cells. This protein helps cancer cells evade the immune system, so blocking it allows the immune system to recognize and attack the cancer cells.
How is Atezolizumab Used?
Atezolizumab is used to treat a type of breast cancer called triple-negative breast cancer. Triple-negative breast cancer is a type of breast cancer that does not have receptors for estrogen, progesterone, or HER2. This makes it more difficult to treat than other types of breast cancer.
What are the Benefits of Atezolizumab?
Atezolizumab has been shown to be effective in treating triple-negative breast cancer. In a clinical trial, atezolizumab was shown to improve the survival of patients with triple-negative breast cancer by 10 months.
What are the Side Effects of Atezolizumab?
Atezolizumab can cause a number of side effects, including fatigue, nausea, vomiting, diarrhea, and rash. In some cases, atezolizumab can also cause more serious side effects, such as liver damage and kidney damage.
Conclusion
Atezolizumab is a new type of immunotherapy drug that has been shown to be effective in treating triple-negative breast cancer. However, it is important to be aware of the potential side effects of atezolizumab before starting treatment.
Komentar